The primate-specific serum protein apolipoprotein L1 (APOL1) is the only secreted member of a family of cell death promoting proteins 1-4 . APOL1 kills the bloodstream parasite Trypanosoma brucei brucei, but not the human sleeping sickness agents T.b. rhodesiense and T.b. gambiense 3 . We considered the possibility that intracellular members of the APOL1 family, against which extracellular trypanosomes could not have evolved resistance, could kill pathogenic T. brucei subspecies. Here we show that recombinant APOL3 (rAPOL3) kills all African trypanosomes, including T.b. rhodesiense, T.b. gambiense and the animal pathogens Trypanosoma evansi, Trypanosoma congolense and Trypanosoma vivax. However, rAPOL3 did not kill more distant trypanosomes such as Trypanosoma theileri or Trypanosoma cruzi. This trypanolytic potential was partially shared by rAPOL1 from Papio papio (rPpAPOL1). The differential killing ability of rAPOL3 and rAPOL1 was associated with a distinct dependence on acidic pH for activity. Due both to its instability and toxicity when injected into mice, rAPOL3 cannot be used for the treatment of infection, but an experimental rPpAPOL1 mutant inspired by APOL3 exhibited enhanced trypanolytic activity in vitro and the ability to completely inhibit T.b. gambiense infection in mice. We conclude that pH dependence influences the trypanolytic potential of rAPOLs.
probably quickly degraded 3, 12 . APOL1 cannot kill T.b. gambiense and T.b. rhodesiense, because these subspecies express different APOL1 resistance proteins in the endocytic pathway 3, 5, 13, 14 . While the T.b. rhodesiense endolysosomal serum resistance-associated protein (SRA) neutralizes APOL1 through direct interaction with the C-terminal amphipathic helix of APOL1 3, 5, 13 , the T.b. gambiensespecific glycoprotein TgsGP, characteristic of type I but not type II T.b. gambiense, inactivates APOL1 through its ability to stiffen membranes, presumably hampering APOL1 insertion in endosomal membranes 3, 14, 15 . Both resistance proteins evolved from the main surface component of the parasite, termed VSG (for 'variant surface glycoprotein'), the continuous sequence changes of which underlie antigenic variation 3 . Experimental sequence variation within the C-terminal helix can allow rAPOL1 to escape neutralization by SRA and therefore to kill T.b. rhodesiense 16 . Interestingly, natural amino-acid substitutions in the C-terminal region of APOL1 have been strongly selected in Africa, presumably because they confer human resistance to T.b. rhodesiense, despite the fact that these substitutions are also associated with renal disease 17 . Similarly, the variant C-terminal sequence of Papio papio APOL1 (PpAPOL1) allows this primate APOL1 to escape neutralization by SRA and to kill T.b. rhodesiense 18 .
From sequence comparisons, the six members of the human APOL family appear to be highly similar 19 . We thus speculated that these proteins could share the membrane pore-forming activity of APOL1. If so, intracellular APOLs could also be trypanolytic, and we envisaged that African trypanosomes, which are exclusively extracellular, could not have evolved natural resistance against these APOLs. We incubated various trypanosome species and subspecies with different recombinant APOLs (rAPOLs). Among these proteins, rAPOL3 exhibited potent trypanolytic activity on T.b. brucei, in keeping with the relative conservation of the helices defined for APOL1 6 (Supplementary Figs. 1 and 2) . Moreover, close to the concentration range of APOL1 in plasma (0.4-15 µ g ml −1 ; ref. 20 ), rAPOL3 also efficiently killed different trypanosomes closely related to T. brucei, including T.b. rhodesiense, T.b. gambiense types I and II, T. evansi, T. congolense and T. vivax (Fig. 1) . In contrast, rAPOL3 did not kill more distantly related trypanosomes such as T. theileri, T. lewisi or T. musculi (Fig. 1 ). Under the same conditions and concentration, rPpAPOL1 efficiently killed T.b. rhodesiense, but exhibited only weak activity on T.b. gambiense type I (Fig. 1b) .
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The phenotype of rAPOL3-mediated lysis of T.b. brucei differed from that induced by rAPOL1. rAPOL3 triggered the formation of multiple intracellular vesicles instead of the unique large vesicle typically observed with APOL1 6, 7, 21, 22 (Fig. 2a ). Moreover, some of the rAPOL3-induced vesicles exhibited a dense coat comparable with that of the plasma membrane, in clear contrast with rAPOL1induced vesicles, which never showed such characteristics 3,5-7,21,22 ( Fig. 2a ). As the swollen vesicle induced by rAPOL1 is the lysosome 3,5,7 , these findings suggested that rAPOL3 could trigger endosome swelling earlier than rAPOL1. The actin inhibitor latrunculin A inhibited lysis by both rAPOL1 and rAPOL3, suggesting active protein uptake in both cases ( Fig. 2b ). Like rAPOL1 (refs 5,7,9,12 ), rAPOL3 was taken up through the endocytic compartment between the kinetoplast and the nucleus, and was sensitive to cathepsin digestion ( Supplementary Fig. 3a ). However, in contrast to rAPOL1, rAPOL3 efficiently induced trypanolysis at low temperatures, suggesting less dependence on endocytosis for membrane insertion ( Supplementary Fig. 3b ). While, as exp ected 3, 6, 7, [9] [10] [11] , rAPOL1 activity on membranes was inhibited by preventing vacuolar acidification as occurs after incubation with the endosome basifying agents NH 4 Cl or chloroquine, or by RNAi-mediated knockdown of the vacuolar ATPase, rAPOL3mediated lysis resisted all these treatments ( Fig. 2c ). Together, these results suggested that, unlike APOL1, rAPOL3 does not require acidic pH for activity, and could insert into membranes before rAPOL1. In support of this conclusion, rAPOL3-mediated lysis did not involve membrane transport by the kinesin TbKIFC1, which appears to recruit acidic vesicles 23 and participates in both rAPOL1 (ref. 7 ) and rPpAPOL1 activity, as demonstrated by the reduction of APOL1-mediated trypanolysis in parasites with RNAi-mediated TbKIFC1 knockdown ( Fig. 2d and Supplementary Fig. 4 ). Further downstream in the process of lysis, no difference could be demonstrated between the APOLs, because typical features linked to APOL1 death-promoting activity, like mitochondrial membrane depolarization and fenestration or nuclear heterochromatinization 7 , were also observed with rAPOL3 ( Fig. 2e,f and Supplementary Fig. 5 ).
The reason for the differential dependence on acidic conditions for activity could be the clear distinction between the two proteins with respect to their theoretical ability to insert a doublestranded hairpin structure in membranes at neutral pH, this hairpin being the core of the colicin-like pore-forming domain of APOL1 6, 7 . Although APOL1 only exhibited a single transmembrane span, APOL3 contained two ( Fig. 3a,c ). As expected from these theoretical predictions, when assayed in Escherichia coli 16 , rAPOL3 was fully active under both neutral and acidic conditions, in sharp contrast with rAPOL1, which was only active at acidic pH ( Fig. 3a,c) . This difference could be attributed to the presence in APOL1, but not in APOL3, of three glutamic acid residues within or close to helix 9 (shown in bold in Fig. 3c ). Indeed, negatively charged side chains hinder membrane insertion at neutral pH, and their protonation at low pH is required to trigger transmembrane insertion 24 . We evaluated this possibility by swapping residues at these positions between APOL1 and APOL3, both in silico and experimentally. As shown in Fig. 3b (left), inserting in APOL3 the three APOL1-specific glutamic acid residues resulted in the theoretical inability of helix 9 to span a membrane at neutral pH. Accordingly, in E. coli this variant version of rAPOL3 (rMUT1) exhibited almost complete inactivation at neutral pH ( Fig. 3b , centre). Similarly, the trypanolytic activity of rMUT1 on both T.b. brucei and T.b. gambiense was fully inhibited after vacuolar basification with NH 4 Cl (Fig. 3b, right) , which is remarkable in the former case given the particularly high trypanolytic activity of rAPOL3 in the presence of NH 4 Cl (Fig. 3a, right) . Introducing only some of the three glutamic acids did not result in reversion of the rAPOL3 independence to acidic pH ( Supplementary Fig. 6 ). Thus, for APOL3, the absence of these three glutamic acids was necessary and sufficient to explain the protein pore-forming activity at neutral pH. For APOL1 this conclusion could not be confirmed, as in this case no change of activity was observed following amino acid swapping with APOL3 (rMUT2), despite the theoretical prediction that the transmembrane potential of helix 9 can be affected ( Fig. 3d ). Thus, even with two potential transmembrane spans at neutral pH, such as in rMUT2, rAPOL1 activity a T.b. brucei (328-114) 
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NATure MicrObiOLOgy remained dependent on acidic conditions. This observation was also valid for rPpAPOL1, which only contains a single glutamic acid in helix 9 and exhibits two possible transmembrane segments at neutral pH ( Fig. 3e ). We attempted to define which APOL1 segment would be responsible for the pH dependence, by swapping domains between rAPOL1 and rAPOL3 and evaluating the ability of the APOL chimaeras to kill T.b. gambiense. Among five such chimaeras, only two resisted inactivation, and from their relative activity on T.b. gambiense it could be concluded that the APOL sensitivity to pH resides in the pore-forming domain ( Supplementary Fig. 7a ,c). Attempts to define this character more precisely by site-directed mutagenesis within this domain were unsuccessful ( Supplementary Fig. 7b ).
To evaluate the usefulness of rAPOL3 to treat sleeping sickness we tested the effect of intravenous injection of rAPOL3 or rAPOL1 into mice. As expected for a protein normally not present in serum, rAPOL3 disappeared from the bloodstream more rapidly than rAPOL1, with half-lives of ~13 h and 50 h, respectively ( Fig. 4a and Supplementary Fig. 8 ). Moreover, injection of rAPOL3 was clearly toxic, as, depending on the dose, it induced pathology or death of the mice within one day, whereas all mice safely survived injection of either rAPOL1, rPpAPOL1or an inactivated mutant of rAPOL3 (rMUT-null) ( Supplementary  Table and Supplementary Fig. 9 ). Being dependent on protein activity, rAPOL3 toxicity could hypothetically result from pore formation into host membranes. Thus, due to both its instability and toxicity, rAPOL3 cannot be considered for treatment of infection in vivo.
So far, PpAPOL1 has been presented as the best trypanolytic protein for use in the field 25 , because PpAPOL1 cannot be inactivated 
NATure MicrObiOLOgy by the T.b. rhodesiense resistance protein SRA, and therefore kills this human pathogen 18 . Moreover, it was suggested that PpAPOL1 also efficiently kills T.b. gambiense, although this issue remains controversial because it has only been documented in vitro, and there is evidence for natural tolerance of both Papio papio and Papio hamadryas to infection by T.b. gambiense [26] [27] [28] . Although rAPOL3 and rPpAPOL1 resistance to SRA is expected to result from sequence differences in the C-terminal region 16, 18 , the ability of rAPOL3 to kill T.b. gambiense, and thus rAPOL3 resistance to TgsGP, could hypothetically be linked to an independence of acidic conditions for membrane insertion. TgsGP protects a restricted fraction (7%) of endosomal membranes against APOL1, in a defined region close to the flagellar pocket 14 . Given the results presented in Fig. 2a-d and Supplementary Fig. 3 , we hypothesize that, in contrast to rAPOL1, rAPOL3 could be able to insert into membranes before reaching the TgsGP-containing endosomal compartment. In line with this speculative view, the ability of rPpAPOL1 to partially resist TgsGP could result from some membrane insertion before the acidic compartment, due to the absence of two of the three APOL1-specific glutamic acid residues in helix 9. We tested this hypothesis by replacing the last glutamic acid of PpAPOL1 helix 9 (E195) with the corresponding amino acid in APOL3 (A221) (Fig. 3f ). Strikingly, this single substitution increased by 100-fold the ability of PpAPOL1 to kill E. coli at neutral pH ( Fig. 3f, centre) , and it allowed a more efficient killing activity of PpAPOL1 on all different strains of T.b. gambiense that we tested ( Fig. 3f right, Fig. 4b and Supplementary Fig. 10 ). b, rMUT1, a rAPOL3 mutant (residues in bold red). c, Wild-type rAPOL1. d, rMUT2, a rAPOL1 mutant (residues in bold red). e, Wild-type Papio papio APOL1 (rPpAPOL1). f, rPpMUT, a rPpAPOL1 mutant (residues in bold red).
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In contrast to what is observed with rAPOL3, the activity of rPpA-POL1 E195A (rPpMUT) was still inhibited by NH 4 Cl (Fig. 3f, right) and was still increased by TbKIFC1 (Fig. 4c ), suggesting that, as occurs for rAPOL1, rPpMUT still contains a pH-sensitive element outside helix 9. Despite this residual pH dependence, when injected into mice 24 h after intravenous inoculation of 1 × 10 6 LiTat 1.3 T.b. gambiense parasites, 100 µ g rPpMUT was necessary and sufficient to strongly reduce the first parasitaemia peak and then completely clear infection, in sharp contrast to observations made with similar amounts of either rAPOL1 or rPpAPOL1 (Fig. 4d ).
In all trypanolysis experiments conducted in this work, the killing efficiency of the various APOLs was variable between different trypanosome populations. For T.b. gambiense, this variability could possibly depend on the relative level of TgsGP, but it could also be influenced by the type of VSG coat or the relative adaptation of the parasites to in vitro conditions. The rate of T.b. gambiense trypanolysis by rPpMUT was inversely correlated with the relative growth of trypanosomes ( Supplementary  Fig. 10a ), and not with the VSG type ( Supplementary Fig. 10b ) or TgsGP level ( Supplementary Fig. 10c ). Differential in vitro adaptation could explain the discrepancy between the reported efficient T.b. gambiense killing activity of rPpAPOL1 in vitro 28 and both our observations of poor in vitro activity of this protein and the known natural tolerance of different Papio species to in vivo infection by T.b. gambiense 27 .
In summary, we have identified two rAPOL variants able to efficiently lyse both T.b. rhodesiense and T.b. gambiense in vitro, associated with a reduced dependence on acidic pH for activity. The high trypanolytic activity of one of these variants in mice offers promising prospects for the treatment of sleeping sickness. Production of rAPOLs. The various recombinant proteins were all prepared according to a previously described procedure 5, 6 . Briefly, C-terminal His6-tagged rAPOLs were purified after expression from the pET21d vector in E. coli following a 4 h induction at 37 °C with 1 mM isopropyl-β -d-thiogalactoside. After washing, inclusion bodies were dissolved in 6 M guanidium-hydrochloric acid and 50 mM phosphate buffer (pH 8.0) and incubated with Ni-NTA beads for 16 h at 4 °C. All washing steps occurred at pH 8.0. After elution with 250 mM imidazole, the proteins were extensively dialysed against 20 mM acetic acid. APOL3 isoform 2 was chosen, as this isoform appears to be the most expressed one in different human cell lines. The purity and concentration were verified by SDS-PAGE and Coomassie blue staining. At least three independent preparations were analysed, with similar results. For rAPOL3, a fraction of the protein systematically precipitated in the trypanosome incubation medium. This fraction represented ~60% of the protein ( Supplementary Fig. 11 ). Therefore, the effective concentration of rAPOL3 in our in vitro trypanolysis assays was probably lower than indicated. For rPpAPOL1, the synthetic gene based on the available coding sequence (EMBL-EBI: AGM15879.1) was ordered from Life Technologies. For rPpMUT, one codon was synthetically replaced, resulting in E195A sequence modification.
Antibodies. Rabbit anti-APOL1 antibodies were obtained from Sigma-Aldrich (HPA018885). To detect rAPOL3 and rPpAPOL1, we used rat antibodies raised against rAPOL3 and rAPOL1, respectively. To detect TbKIFC1, we used the mouse monoclonal anti-TbKIFC1 antibody (H3) 23 .
Western blotting. The protein extracts were separated on SDS-PAGE gel. Protein transfer was realized onto Hybond-P membrane (Amersham) by electrotransfer in 25 mM Tris, 192 mM glycine, 20% methanol (pH 8.3) for 1 h at 100 V. Membranes were blocked by incubation with 5% skimmed milk powder in 137 mM NaCl, 2.7 mM KCl and 10 mM Na 2 HPO 4 (pH 7.4) and were then incubated with antibodies in 150 mM NaCl, 50 mM Tris (pH 7.5) and 3.5% milk powder overnight at 4 °C. Secondary antibodies were diluted in 150 mM NaCl, 50 mM Tris (pH 7.5) and the bound antibodies were detected by chemiluminescence (Perkin Elmer).
In vitro trypanolysis and growth assays. Lysis assays were performed as described in refs 5, 6 . Briefly, trypanosomes isolated from mice were incubated at 10 5 ml −1 in HMI-9 supplemented medium at 37 °C in a CO 2 -equilibrated incubator. At the indicated times, living trypanosomes were counted in triplicate under the microscope. In these assays, the volume of the APOL samples, in 20 mM acetic acid (pH 5), was kept constant so that there was no difference in acetic acid content between samples. In vitro growth assays were performed by daily dilutions of trypanosomes at 10 5 ml −1 in HMI-9 supplemented medium. Normalizations were performed to untreated controls. For the comparative measurement of the temperature effect on rAPOL1 and rAPOL3 uptake in T.b. gambiense, TgsGP KO LiTat 1.3 parasites were diluted in IMDM complete medium containing 25 mM Hepes (pH 7.5) and cooled to 4 °C. rAPOL1 or rAPOL3 (or the acetic acid solvent alone for control growth) were added to the parasites and the mixture was divided into 0.5 ml tubes. Parasites were further incubated for 18 h at 15 °C, 20 °C, 26 °C, 30 °C and 37 °C before counting.
In vivo growth assays. A total of 10 6 trypanosomes in 100 μ l Phosphate-buffered Saline Glucose (PSG) medium were injected intravenously into 6-week-old female BALB/c mice. Daily, 2 μ l tail blood samples were diluted in erythrocyte lysis buffer (0.85% (wt/vol) NH 4 Cl, 10 mM Tris pH 7.4) and counted with a haemocytometer. Sample size was empirically estimated and validated by the stability of the standard deviation of the growth curves. Within each experiment, the animals were morphologically indistinguishable (same strain, age and weight) and were allocated randomly to each group. No blinding was performed.
Pore-forming activity in bacteria. Cultures of SE1 (Staby) strains transfected with pStaby1.2 (Delphi Genetics) harbouring the different APOL constructs were grown at 37 °C in Lysogeny Broth (LB) medium containing 1% glucose and 50 μ g ml −1 ampicillin from freshly plated colonies, until reaching an optical density at 600 nm (OD 600 ) of 0.7-0.8. Ten-times serial dilutions were plated (5 µ l spots) onto a squared LB petri dish containing agar in pH-buffered LB (5.5 or 7.5) (1% tryptone, 0.5% yeast extract, 0.5% NaCl, 1.5% agar, 50 mM MES, 50 mM HEPES, pH adjusted), 50 μ g ml −1 ampicillin and either 1% glucose (non-induced control) or 75 μ M IPTG (induction of recombinant proteins). Spot strips were compared after overnight incubation at 37 °C. These results reflect the pore-forming activity of APOLs 6, 16 .
Live light microscopy and flow cytometry. For live microscopy, trypanosomes were mounted on a 1% low-melting-point agarose pad sealed with rubber glue. Cells were imaged in a single plane with an Axioimager M2 widefield fluorescence microscope with a × 100 Plan-APOCHROMAT 1.4 objective. For the mitochondrial membrane polarity evaluation, trypanosomes were incubated for at least 15 min with 25 pM tetramethylrhodamine ethyl ester perchlorate (TMRE) (Life Technology) before treatment. For flow cytometry, cells were analysed with a Fluorescence-Activated Cell Sorter (FACS) canto II. A total of 20,000 live cells were analysed based on the gating. One morphological Forward Scager/Side Scager (FSC/SSC) gate was performed, followed by one FSC-H/FSC-A gate for effective singlet isolation. The mean fluorescence intensity (MFI) of the gated cells was measured for the TMRE staining (PE-filter). FACS data were analysed further using FlowJo.
Transmission electron microscopy. Cells were fixed for 1 h at room temperature in 2.5% glutaraldehyde in culture medium, and postfixed in 2% OsO 4 in the same buffer. After serial dehydration in increasing ethanol concentrations, samples were embedded in agar 100 (Agar Scientific) and left to polymerize for 2 days at 60 °C. Ultrathin sections (50-70 nm thick) were collected in Formvar-carboncoated copper grids using a Leica EM UC6 ultramicrotome and stained with uranyl acetate and lead citrate. Observations were made on a Tecnai10 electron microscope (FEI), and images were captured with an Olympus VELETA camera and processed with AnalySIS software.
Focused ion beam-scanning electron microscopy. Samples were incubated in fixative (2% paraformaldehyde (PFA), Applichem), 2.5% gluteraldehyde (GA, EMS) in 0.15 M sodium cacodylate (Sigma-Aldrich) buffer (pH 7.4) at room temperature (RT) for 30 min. Fixative was removed by washing five times for 3 min each in 0.15 M cacodylate buffer and samples were incubated in 1% osmium (OsO 4 , EMS), 1.5% potassium ferrocyanide (Sigma-Aldrich) in 0.15 M cacodylate buffer for 40 min at RT. This was immediately followed by a second incubation in OsO 4 (1% osmium in double-distilled H 2 O (ddH 2 O) for 40 min at RT. After washing in ddH 2 O five times for 3 min each, samples were incubated overnight at 4 °C in 1% uranyl acetate (UA, EMS). The UA was removed by washing in ddH 2 O five times for 3 min each and subsequently dehydrated and embedded as indicated above. Embedded samples were then mounted on aluminium scanning electron microscopy (SEM) stubs (diameter, 12 mm) and coated with ~8 nm platinum (Quorum Q150T ES). Focused ion beam (FIB)-SEM imaging was performed using a Zeiss Auriga Crossbeam system with Atlas3D software. The FIB was set to remove 5 nm sections by propelling gallium ions at the surface. Imaging was carried out at 1.5 kV using an ESB (back-scattered electron) detector. Three-dimensional reconstruction and segmentation were generated from the image stacks using Fiji ImageJ (National Institutes of Health) and ilastik software.
Fluorescence imaging of rAPOL3 uptake. Parasites were preincubated in culture medium supplemented with 20 µ M FMK-064 for 15 min at 37 °C before addition of rAPOL3 for 15 min. Detection of rAPOL3 was performed with anti-rAPOL3 rat antibodies and Alexa488 anti-rat antibodies after Triton × 100 permeabilization.
Data availability. The authors declare that the data supporting the findings of this study are available within the paper and its Supplementary Information files. Corresponding author(s): Etienne Pays
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